|
NL257307A
(enExample)
|
1959-10-28 |
|
|
|
|
US3686238A
(en)
|
1970-01-19 |
1972-08-22 |
Syntex Corp |
Glycerol esterified with 2-naphthyl-acetic acids and fatty acids
|
|
US20030083272A1
(en)
|
1997-09-19 |
2003-05-01 |
Lahive & Cockfield, Llp |
Sense mrna therapy
|
|
US6670499B1
(en)
|
1999-11-08 |
2003-12-30 |
Daicel Chemical Industries, Ltd. |
Adamantane derivatives and processes for the preparation thereof
|
|
CA2429814C
(en)
|
2000-12-01 |
2014-02-18 |
Thomas Tuschl |
Rna interference mediating small rna molecules
|
|
US20040077888A1
(en)
|
2002-05-31 |
2004-04-22 |
The Regents Of The University Of California |
Polyamine-mediated transfection
|
|
JP2005181734A
(ja)
|
2003-12-19 |
2005-07-07 |
Fuji Photo Film Co Ltd |
画像記録材料
|
|
DE102007029471A1
(de)
|
2007-06-20 |
2008-12-24 |
Novosom Ag |
Neue fakultativ kationische Sterole
|
|
CA2721333C
(en)
|
2008-04-15 |
2020-12-01 |
Protiva Biotherapeutics, Inc. |
Novel lipid formulations for nucleic acid delivery
|
|
KR20190039347A
(ko)
|
2010-06-03 |
2019-04-10 |
알닐람 파마슈티칼스 인코포레이티드 |
활성제의 전달을 위한 생분해성 지질
|
|
PE20181541A1
(es)
|
2011-10-27 |
2018-09-26 |
Massachusetts Inst Technology |
Derivados de aminoacidos funcionalizados en la terminal n capaces de formar microesferas encapsuladoras de farmaco
|
|
WO2013086354A1
(en)
|
2011-12-07 |
2013-06-13 |
Alnylam Pharmaceuticals, Inc. |
Biodegradable lipids for the delivery of active agents
|
|
CN107879960B
(zh)
|
2013-03-08 |
2021-06-22 |
诺华股份有限公司 |
用于传递活性成分的脂质和脂质组合物
|
|
US20150165054A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting caspase-9 point mutations
|
|
EP3083556B1
(en)
*
|
2013-12-19 |
2019-12-25 |
Novartis AG |
Lipids and lipid compositions for the delivery of active agents
|
|
US10426737B2
(en)
|
2013-12-19 |
2019-10-01 |
Novartis Ag |
Lipids and lipid compositions for the delivery of active agents
|
|
US10125092B2
(en)
|
2014-09-05 |
2018-11-13 |
Novartis Ag |
Lipids and lipid compositions for the delivery of active agents
|
|
ES2880103T3
(es)
|
2015-05-21 |
2021-11-23 |
Ohio State Innovation Foundation |
Derivados de benceno-1, 3, 5-tricarboxamida y usos de los mismos
|
|
JP6948313B6
(ja)
|
2015-09-17 |
2022-01-14 |
モデルナティエックス インコーポレイテッド |
治療剤の細胞内送達のための化合物および組成物
|
|
IL310721B2
(en)
|
2015-10-23 |
2025-11-01 |
Harvard College |
Nucleobase editors and uses thereof
|
|
HRP20230209T1
(hr)
|
2015-10-28 |
2023-04-14 |
Acuitas Therapeutics Inc. |
Novi lipidi i lipidne formulacije nanočestica za isporuku nukleinskih kiselina
|
|
LT3436077T
(lt)
|
2016-03-30 |
2025-06-25 |
Intellia Therapeutics, Inc. |
Lipidų nanodalelių vaisto formos, skirtos crispr/cas komponentams
|
|
CN110214183A
(zh)
|
2016-08-03 |
2019-09-06 |
哈佛大学的校长及成员们 |
腺苷核碱基编辑器及其用途
|
|
EP4186888B1
(en)
|
2017-03-15 |
2025-11-26 |
ModernaTX, Inc. |
Compound and compositions for intracellular delivery of therapeutic agents
|
|
BR112019025104A2
(pt)
|
2017-05-30 |
2020-06-23 |
Glaxosmithkline Biologicals S.A. |
Método de fabricar um sistema de entrega não viral, sistema de entrega não viral, e, composição
|
|
CN120682290A
(zh)
|
2017-07-04 |
2025-09-23 |
尹图赛利有限公司 |
包含可裂解接头的化合物及其用途
|
|
CA3081414A1
(en)
|
2017-10-30 |
2019-05-09 |
Georgia Tech Research Corporation |
Multiplexed analysis of materials for tissue delivery
|
|
US11622942B2
(en)
|
2017-11-14 |
2023-04-11 |
Ohio State Innovation Foundation |
Benzene-1,3,5-tricarboxamide derived ester lipids and uses thereof
|
|
EP3727362A4
(en)
|
2017-12-19 |
2021-10-06 |
PureTech LYT, Inc. |
MYCOPHENOLIC ACID LIPID PRODRUGS AND THEIR USES
|
|
TWI894123B
(zh)
|
2017-12-27 |
2025-08-21 |
日商武田藥品工業有限公司 |
含核酸之脂質奈米粒子及其用途
|
|
CN112955099B
(zh)
|
2018-07-27 |
2024-04-26 |
雷森斯医疗有限公司 |
医疗冷却装置和使用其的冷却方法
|
|
CA3107481A1
(en)
|
2018-08-02 |
2020-02-06 |
Puretech Lyt, Inc. |
Lipid prodrugs of pregnane neurosteroids and uses thereof
|
|
EP3842538A4
(en)
|
2018-08-10 |
2022-06-08 |
Kyoto University |
METHOD OF TRANSFECTION INTO CARDIOMYOCYTES USING CATIONIC LIPID
|
|
US20220009878A1
(en)
|
2018-10-02 |
2022-01-13 |
Intellia Therapeutics, Inc. |
Ionizable amine lipids
|
|
BR112021010853A2
(pt)
|
2018-12-05 |
2021-08-31 |
Intellia Therapeutics, Inc. |
Lipídios de amina modificados
|
|
CN119700703A
(zh)
|
2019-01-17 |
2025-03-28 |
佐治亚技术研究公司 |
含有氧化的胆固醇的药物递送系统
|
|
US11845874B2
(en)
|
2019-01-24 |
2023-12-19 |
Agfa Nv |
Radiation curable inkjet inks for interior decoration
|
|
JP7693552B2
(ja)
|
2019-02-13 |
2025-06-17 |
ビーム セラピューティクス インク． |
アデノシンデアミナーゼ塩基エディターおよびそれを用いて標的配列中の核酸塩基を改変する方法
|
|
CA3130349A1
(en)
|
2019-02-28 |
2020-09-03 |
Puretech Lyt, Inc. |
Lipid prodrugs of jak inhibitors and uses thereof
|
|
WO2020176856A1
(en)
|
2019-02-28 |
2020-09-03 |
Puretech Lyt, Inc. |
Lipid prodrugs of glucocorticoids and uses thereof
|
|
WO2020176868A1
(en)
|
2019-02-28 |
2020-09-03 |
Puretech Lyt, Inc. |
Lipid prodrugs of btk inhibitors and uses thereof
|
|
CN114127044A
(zh)
*
|
2019-04-25 |
2022-03-01 |
英特利亚治疗股份有限公司 |
可电离的胺类脂质和脂质纳米颗粒
|
|
JP2022536112A
(ja)
|
2019-06-05 |
2022-08-12 |
ガイド セラピューティクス，インコーポレーテッド |
組織送達のための材料の分析
|
|
WO2020246581A1
(ja)
|
2019-06-07 |
2020-12-10 |
富士フイルム株式会社 |
脂質組成物
|
|
WO2021021636A1
(en)
|
2019-07-29 |
2021-02-04 |
Georgia Tech Research Corporation |
Oligonucleotide antagonists for rna guided genome editing
|
|
CA3145913A1
(en)
|
2019-07-29 |
2021-02-04 |
James Everett Dahlman |
Nanomaterials containing constrained lipids and uses thereof
|
|
CN114901799A
(zh)
|
2019-10-21 |
2022-08-12 |
弗拉斯沃克斯有限责任公司 |
用于细胞培养的系统和方法
|
|
KR20220113737A
(ko)
|
2019-12-06 |
2022-08-16 |
가이드 테라퓨틱스 엘엘씨 |
나노물질
|
|
IL294318A
(en)
*
|
2020-01-09 |
2022-08-01 |
Guide Therapeutics Llc |
Nanomaterials
|
|
JP2023549011A
(ja)
*
|
2020-09-15 |
2023-11-22 |
ヴァーヴ・セラピューティクス，インコーポレーテッド |
遺伝子編集のための脂質製剤
|
|
EP4262818A4
(en)
|
2020-12-21 |
2025-03-26 |
Beam Therapeutics Inc. |
NANOMATERIALS WITH CARBONATES
|
|
JP2024503976A
(ja)
|
2020-12-21 |
2024-01-30 |
ビーム セラピューティクス インク． |
アセタールを含むナノ材料
|
|
EP4262819A4
(en)
|
2020-12-21 |
2024-12-04 |
Beam Therapeutics Inc. |
NANOMATERIALS WITH ESTER-BOUND ACETALS
|
|
EP4281080A4
(en)
|
2021-01-20 |
2025-09-24 |
Beam Therapeutics Inc |
NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT
|
|
JP2024503441A
(ja)
|
2021-01-20 |
2024-01-25 |
ビーム セラピューティクス インク． |
イオン化可能な脂質を含むナノ材料
|
|
CA3203784A1
(en)
|
2021-01-20 |
2022-07-28 |
Beam Therapeutics Inc. |
Ionizable lipids for nanomaterials
|
|
CN116761888A
(zh)
|
2021-01-20 |
2023-09-15 |
比姆医疗股份有限公司 |
纳米材料
|
|
JP2024536406A
(ja)
*
|
2021-10-08 |
2024-10-04 |
スージョウ・アボジェン・バイオサイエンシズ・カンパニー・リミテッド |
脂質化合物及び脂質ナノ粒子組成物
|
|
WO2023121970A1
(en)
|
2021-12-20 |
2023-06-29 |
Beam Therapeutics Inc. |
Ionizable amine and ester lipids and lipid nanoparticles
|
|
EP4452942A1
(en)
|
2021-12-20 |
2024-10-30 |
Beam Therapeutics Inc. |
Nanomaterials comprising disulfides
|
|
JP2025500824A
(ja)
|
2021-12-20 |
2025-01-15 |
ビーム セラピューティクス インク． |
四価脂質化合物を含むナノ材料
|
|
EP4452925A1
(en)
|
2021-12-20 |
2024-10-30 |
Beam Therapeutics Inc. |
Nanomaterial comprising diamines
|
|
CA3241488A1
(en)
|
2021-12-20 |
2023-06-29 |
Beam Therapeutics Inc. |
Ionizable amine lipids and lipid nanoparticles
|
|
CA3260437A1
(en)
|
2022-07-20 |
2024-01-25 |
Beam Therapeutics Inc. |
NANOMATERIALS INCLUDING TRIOLS
|